Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 18;24(1):3461.
doi: 10.1186/s12889-024-20891-1.

Association of altitude with all-cause and cardiovascular mortality among patients with hypertension: a cohort study in Southwest China

Affiliations

Association of altitude with all-cause and cardiovascular mortality among patients with hypertension: a cohort study in Southwest China

Yu Xia et al. BMC Public Health. .

Abstract

Background: Available evidence falls short in assessing the risk of long-term outcomes among individuals with hypertension residing at various altitudes. We aimed to investigate the association between residential altitude and the risk of all-cause and cardiovascular disease (CVD) mortality among hypertensive patients.

Methods: This cohort study encompassed 67,275 hypertensive patients aged ≥35 years who participated in China's Basic Public Health Service Program in 2018. Participants were categorized into four groups based on their residence altitude: <500 m, 500-1,499 m, 1,500-2,500 m, and > 2,500 m. The associations between residential altitude and the risks of all-cause and CVD mortality were analyzed using Cox proportional hazards regression models. The dose-response relationship was performed by the restricted cubic spline with multivariable adjusted models.

Results: Among the 67,275 hypertensive patients included in the study (mean age of 63.9 years, with 45.3% male), 8,768 deaths were recorded, of which 5,666 were attributed to CVD. Following multivariate adjustment, when compared to the group residing at altitudes < 500 m, the groups living at altitudes of 500-1,499 m, 1500-2,500 m, and > 2,500 m exhibited significantly risks of all-cause mortality [HR = 1.45 (95% CI: 1.36-1.54), 1.35 (95% CI: 1.28-1.43), and 1.41 (95% CI: 1.28-1.54), respectively] and CVD mortality [HR = 1.47 (95% CI: 1.35-1.58), 1.42 (95% CI: 1.33-1.52), and 1.46 (95% CI: 1.31-1.62), respectively]. The restricted cubic spline curves revealed a nonlinear relationship between residential altitude and all-cause and CVD mortality. The risk of mortality was higher among participants with poorly controlled blood pressure, aged 65 years and above, and living in rural areas.

Conclusions: This study demonstrated a significant association between long-term residential high-altitude exposure and increased risks of all-cause and CVD mortality among hypertension patients. The implications of the findings call for a prioritization of public health resource allocation and early intervention efforts, especially for those living at high altitudes and in low-income areas where hypertension is prevalent.

Keywords: Altitude; Cardiovascular disease; Hypertension; Mortality.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, and all respondents gave written informed consent according to BPHS requirements. Consent for publication: All authors approve the publication of the final manuscript. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of study sample inclusion
Fig. 2
Fig. 2
Kaplan-Meier curves of all-cause(Left) and CVD(Right) mortality in hypertensive patients
Fig. 3
Fig. 3
Restricted cubic spline regression for the associations between altitude and all-cause(Top) and CVD(Bottom) mortality among hypertension patients
Fig. 4
Fig. 4
Subgroup analysis of residence altitude and all-cause mortality in hypertensive patients. DM: diabetes mellitus; CVD: cardiovascular disease; BP: blood pressure
Fig. 5
Fig. 5
Subgroup analysis of residence altitude and CVD mortality in hypertensive patients. DM: diabetes mellitus; CVD: cardiovascular disease; BP: blood pressure

Similar articles

References

    1. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37. - PMC - PubMed
    1. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet (London, England). 2020;396(10258):1223–1249. - PMC - PubMed
    1. Yin R, Yin L, Li L, Silva-Nash J, Tan J, Pan Z, Zeng J, Yan LL. Hypertension in China: burdens, guidelines and policy responses: a state-of-the-art review. J Hum Hypertens. 2022;36(2):126–34. - PMC - PubMed
    1. Li S, Liu Z, Joseph P, Hu B, Yin L, Tse LA, Rangarajan S, Wang C, Wang Y, Islam S, et al. Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy. Eur Heart J. 2022;43(30):2852–63. - PubMed
    1. Parati G. HIGHCARE: the HIGH altitude CArdiovascular research study: a scientific expedition on Mount Everest to measure the effects of altitude on blood pressure. Eur Heart J. 2015;36(5):260–1. - PubMed

LinkOut - more resources